Stromelysin-1 and Interleukin-6 Gene Promoter Polymorphisms Are Determinants of Asymptomatic Carotid Artery Atherosclerosis
Authors:
- Rainer RauramaaRRRainer Rauramaa
- Sari B. VäisänenSVSari B. Väisänen
- Le-Anh LuongLLLe-Anh Luong
- Arno Schmidt-TrücksässArno Schmidt-Trücksäss
- Ilkka M. PenttiläIPIlkka M. Penttilä
- Claude BouchardCBClaude Bouchard
- Jari TöyryJTJari Töyry
- Steve E. HumphriesSHSteve E. Humphries
- 1 December 2000
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 20 (12) , 2657-2662
Abstract
—The functional 5A/6A polymorphism of the stromelysin-1 promoter has been implicated as a potential genetic marker for the progression of angiographically determined atherosclerosis in patients with coronary artery disease. Recently, a novel interleukin-6 (IL-6) gene functional G/C polymorphism at −174 in the promoter has also been reported. In this study, we analyzed the relation of these two polymorphisms with carotid artery atherosclerosis in 109 randomly selected, middle-aged men without exercise-induced ischemia. Atherosclerosis was quantified as intima-media thickness (IMT) by high-resolution ultrasonography. Univariately, stromelysin genotype was significantly ( P =0.015) associated with IMT, and this relation remained ( P =0.033) after adjustments for age, cardiorespiratory fitness, body mass index, smoking, LDL cholesterol, and systolic blood pressure and for sonographers. The 5A/6A polymorphism independently explained 7% of the variance in carotid bifurcation IMT. The IL-6 polymorphism was also significantly associated ( P =0.036) with increased IMT, with men homozygous for the G allele having IMT that was 11% greater than men homozygous for the C allele. Men who were homozygous for both the 6A and G alleles had an covariate adjusted IMT that was 36% greater than men who were homozygous for neither allele ( P <0.003). These data suggest that genetic factors that predispose to reduced matrix remodeling (stromelysin 6A allele) and to increased inflammation (IL-6 G allele) combine to increase susceptibility for intima-media thickening in the carotid bifurcation, a predilection site for atherosclerosis.Keywords
This publication has 29 references indexed in Scilit:
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.Journal of Clinical Investigation, 1998
- The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil studyAtherosclerosis, 1998
- α, β, γ, and δ T Cell Antigen Receptor Genes Arose Early in Vertebrate PhylogenyImmunity, 1997
- Nicotine and cotinine stimulate secretion of basic fibroblast growth factor and affect expression of matrix metalloproteinases in cultured human smooth muscle cellsJournal of Vascular Surgery, 1996
- Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wallAtherosclerosis, 1996
- Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.Heart, 1995
- Serum glycoproteins and severity of coronary atherosclerosisAmerican Heart Journal, 1995
- Inverse relationship between cardiorespiratory fitness and carotid atherosclerosisAtherosclerosis, 1995
- Synthesis of tissue inhibitor of metalloproteinase‐1 (TIMP‐1) in human hepatoma cells (HepG2) Up‐regulation by interleukin‐6 and transforming growth factor β1FEBS Letters, 1992
- Elevation of C-reactive protein in “active” coronary artery diseaseThe American Journal of Cardiology, 1990